Tilray Brands, Inc. (TLRY) is currently the subject of significant discussion on Reddit forums, with users focusing on the upcoming DEA rescheduling hearing on cannabis. The hearing, scheduled for December 2, is seen as a potential catalyst for the company, although some users express skepticism about immediate impacts. One user noted, "I’m not sure how much this will be a catalyst, bc if I’m not mistaken, the people speaking are the ones who oppose schedule 3." Another user expressed optimism, stating, "No matter all of this is great news. The process is Moving Forward. That’s what’s important."
In addition to the DEA hearing, discussions also highlight Tilray's strategic positioning in the European market. Users are optimistic about the company's established presence in Germany and other European countries, where medical cannabis demand is expected to grow. A user pointed out, "Aphria / Tilray Brands have established Licensed EU GMP certified business to supply into these rapidly expanding markets." This sentiment is echoed by another user who mentioned, "2025 could be a very good year," reflecting anticipation for future growth driven by regulatory changes and market expansion.
As of the current timestamp, Tilray Brands, Inc. (TLRY) is trading at $1.34, with no change from the previous close.